eLikari is a medical consultation platform for patients and doctors, offering audio and video sessions on iOS and Android.
The App DNA
What makes this app unique?
It removes the geographical barrier between patients and specialists by providing a centralized digital space for medical history and follow-up communication.
For Patients seeking remote medical advice and consultations, including those currently located abroad or unable to visit physical clinics.
What does it look like?
Key features
Real-time medical consultations conducted via audio or video calls at pre-arranged times.
Centralized storage for consultation history and test results accessible only to the patient and doctor.
Ability to ask follow-up questions for 10 days after the initial consultation.
How much does it cost?
The platform operates as a technical intermediary with no explicit subscription or per-consultation fee mentioned in the store data.
Velocity
Dormant developmentopaqueShow more...
With the last release occurring 289 days ago, the app has entered a state of inactivity. Development has effectively ceased, as no updates have been pushed to either iOS or Android platforms in nearly ten months. The release history consists solely of minor technical improvements, indicating a lack of ongoing feature development or operational support.
Who built it?
MEDICAL CONSULTING
3 apps tracked · Medical
User Sentiment
What do users think recently?
Review voice lately leans thrilled. Users appreciate intuitive filtering and search tools allow users to quickly locate specific appointment times and stable video connection and professional documentation process provide a reliable remote medical consultation experience.
How are ratings & reviews evolving?
What users say, by theme
- Intuitive filtering and search tools allow users to quickly locate specific appointment times
- Stable video connection and professional documentation process provide a reliable remote medical consultation experience
- Responsive customer support team assists users with initial setup and navigation questions effectively
2 of 2 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for eLikari - doctors online
How's the Medical market?
eLikari holds the #41 position in the Ukrainian Medical category. The lack of a clear monetization model relative to the category norm suggests a focus on user acquisition over direct revenue.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for eLikari - doctors online
Where is it heading?
The telemedicine market is shifting toward integrated health management, and eLikari's current inactivity leaves it exposed. Without a return to active development, the platform will struggle to maintain its position against competitors who are actively expanding their service offerings.
- The 9-month development hiatus suggests a lack of active investment, which will likely lead to user attrition as rivals iterate faster.
The SWOT
- Centralized 'Patient Card' creates longitudinal health record lock-in
- Premium tier integration could capture untapped ARPU
Next best moves
Audit clinical workflow features because the 9-month development gap risks user churn → improve retention
The counter-intuitive read
The lack of monetization is a strategic advantage in the current market…
Read the full takeSince the last report: The competitive outlook for eLikari has shifted from stable to declining due to the persistent nine-month development hiatus. The analysis now explicitly identifies the lack of monetization as a strategic vulnerability and highlights the need for a feature-driven pivot to retain market share.
Bottom line
The current maintenance-only posture leaves eLikari vulnerable to more agile telemedicine rivals. Pivoting to a feature-driven roadmap would unlock the potential of the 'Patient Card' as a long-term retention lever.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing, source
Report last updated